University of Maryland

Respiratory syncytial virus
#ENA Respiratory #Immunology / Virology & Vaccines #Phase II trial #Respiratory #University of Maryland

Vaccine centre hosts study of antiviral host defence enhancer

ENA Respiratory and the University of Maryland have announced plans to partner on a Phase II study of INNA-051 for the prevention of illness due to viral respiratory infections.  Dr Justin Ortiz, Professor of Medicine at the University of Maryland School of Medicine’s Center for Vaccine and… Read More

#News